Could high homocysteine be due to B vitamin deficiency?

High homocysteine levels are often caused by deficiencies in B vitamins, particularly B12, B6, and folate, which are essential for converting homocysteine into other amino acids. Testing your homocysteine and B vitamin levels can help identify deficiencies and guide targeted supplementation to reduce cardiovascular and neurological risks.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Homocysteine and Its Role in Your Body

Homocysteine is an amino acid produced naturally in your body as a byproduct of protein metabolism, specifically from the breakdown of methionine, an essential amino acid found in meat, fish, and dairy products. Under normal circumstances, your body efficiently converts homocysteine into other beneficial compounds through two main pathways: remethylation (converting it back to methionine) and transsulfuration (converting it to cysteine).

However, when these conversion processes are impaired, homocysteine accumulates in your blood, potentially reaching harmful levels. Elevated homocysteine, known as hyperhomocysteinemia, is associated with increased risk of cardiovascular disease, stroke, cognitive decline, and other serious health conditions. The good news is that in many cases, high homocysteine levels can be traced back to a simple nutritional deficiency that's relatively easy to address.

The Critical Connection Between B Vitamins and Homocysteine

B vitamins play an indispensable role in homocysteine metabolism. Three B vitamins in particular—vitamin B12 (cobalamin), vitamin B6 (pyridoxine), and folate (vitamin B9)—act as essential cofactors in the enzymatic reactions that convert homocysteine into other amino acids. Without adequate levels of these vitamins, your body cannot efficiently process homocysteine, leading to its accumulation in the bloodstream.

Homocysteine Level Categories and Health Implications

Homocysteine LevelCategoryHealth RiskRecommended Action
<10 μmol/L<10 μmol/LOptimalLow cardiovascular and cognitive riskMaintain through diet and lifestyle
10-15 μmol/L10-15 μmol/LBorderlineSlightly increased riskConsider B vitamin optimization
15-30 μmol/L15-30 μmol/LModerately ElevatedSignificant cardiovascular riskB vitamin supplementation recommended
>30 μmol/L>30 μmol/LSeverely ElevatedHigh risk of vascular eventsImmediate medical intervention needed

Homocysteine levels should be interpreted alongside B vitamin status and other cardiovascular risk factors.

Vitamin B12: The Methylation Master

Vitamin B12 serves as a crucial cofactor for methionine synthase, the enzyme responsible for converting homocysteine back to methionine. This remethylation pathway is one of the primary routes for homocysteine clearance. B12 deficiency is particularly common among vegetarians and vegans (since B12 is found primarily in animal products), older adults (due to decreased absorption), and individuals with digestive disorders affecting B12 absorption.

Folate: The Methyl Donor

Folate works hand-in-hand with vitamin B12 in the remethylation pathway. It provides the methyl group needed to convert homocysteine to methionine. Folate deficiency can occur due to inadequate dietary intake, malabsorption disorders, certain medications (like methotrexate), or increased needs during pregnancy. Even with adequate B12 levels, folate deficiency alone can cause homocysteine elevation.

Vitamin B6: The Transsulfuration Facilitator

Vitamin B6 is essential for the transsulfuration pathway, where homocysteine is converted to cysteine through a series of enzymatic reactions. This pathway becomes particularly important when methionine intake is high or when the remethylation pathway is compromised. B6 deficiency can result from poor diet, alcohol abuse, certain medications, or inflammatory conditions that increase B6 requirements.

How Common Is B Vitamin Deficiency?

B vitamin deficiencies are more prevalent than many people realize. Studies suggest that up to 40% of older adults have borderline B12 levels, while folate deficiency affects approximately 10% of the U.S. population. Certain groups face higher risks of deficiency:

  • Vegetarians and vegans (particularly for B12)
  • Older adults (reduced absorption and dietary intake)
  • Pregnant and breastfeeding women (increased requirements)
  • Individuals with gastrointestinal disorders (Crohn's disease, celiac disease)
  • People taking certain medications (proton pump inhibitors, metformin, oral contraceptives)
  • Those with alcohol use disorder
  • Individuals with genetic variations affecting B vitamin metabolism (MTHFR mutations)

Regular monitoring of your homocysteine levels alongside B vitamin status can help identify deficiencies before they lead to serious health consequences. Understanding your baseline levels and tracking changes over time provides valuable insights into your metabolic health and cardiovascular risk profile.

Recognizing the Signs of Elevated Homocysteine

High homocysteine levels often develop silently, without obvious symptoms in the early stages. However, as levels rise or persist over time, various signs and symptoms may emerge, often overlapping with those of B vitamin deficiency:

  • Fatigue and weakness
  • Cognitive difficulties (brain fog, memory problems)
  • Mood changes (depression, irritability)
  • Numbness or tingling in extremities
  • Dizziness or balance problems
  • Pale skin or jaundice
  • Shortness of breath
  • Heart palpitations

It's important to note that these symptoms can have many causes, which is why laboratory testing is essential for accurate diagnosis. Homocysteine levels above 15 μmol/L are generally considered elevated, though optimal levels are typically below 10 μmol/L.

Health Risks Associated with High Homocysteine

Elevated homocysteine is not just a marker of B vitamin deficiency—it's an independent risk factor for several serious health conditions. Understanding these risks underscores the importance of maintaining optimal homocysteine levels through adequate B vitamin intake.

Cardiovascular Disease

High homocysteine damages blood vessel walls, promotes inflammation, and increases the risk of blood clots. Studies show that every 5 μmol/L increase in homocysteine raises cardiovascular disease risk by approximately 20%. This includes increased risk of heart attack, stroke, and peripheral artery disease.

Cognitive Decline and Dementia

Elevated homocysteine is associated with brain atrophy, cognitive decline, and increased risk of Alzheimer's disease and vascular dementia. The mechanism likely involves both direct neurotoxic effects and vascular damage in the brain. B vitamin supplementation has shown promise in slowing cognitive decline in individuals with elevated homocysteine.

Pregnancy Complications

High homocysteine during pregnancy increases the risk of neural tube defects, preeclampsia, placental abruption, and recurrent pregnancy loss. This is why folate supplementation is universally recommended during pregnancy, and why monitoring homocysteine can be valuable for women with a history of pregnancy complications.

Testing and Diagnosis: Getting to the Root Cause

Proper diagnosis of elevated homocysteine and its underlying causes requires comprehensive testing. A simple homocysteine blood test can reveal if your levels are elevated, but additional testing is often needed to identify specific B vitamin deficiencies and guide treatment.

Recommended tests include:

  • Homocysteine levels (optimal: <10 μmol/L)
  • Vitamin B12 (optimal: >400 pg/mL)
  • Folate (optimal: >5 ng/mL)
  • Vitamin B6 (as pyridoxal phosphate)
  • Methylmalonic acid (MMA) - a more sensitive marker of B12 deficiency
  • Complete blood count (to check for megaloblastic anemia)

For individuals with persistently elevated homocysteine despite B vitamin supplementation, genetic testing for MTHFR mutations may be warranted. These genetic variations affect how efficiently your body processes folate and can require specialized supplementation approaches. Regular monitoring through comprehensive metabolic panels helps track your progress and ensure your interventions are working effectively.

Treatment Strategies: Lowering Homocysteine Through B Vitamins

The good news about B vitamin deficiency-related hyperhomocysteinemia is that it's highly treatable. Most people see significant improvements in their homocysteine levels within 4-8 weeks of starting appropriate supplementation. However, the key is using the right forms and doses of B vitamins based on your individual needs.

Supplementation Guidelines

Typical supplementation protocols for lowering homocysteine include:

  • Vitamin B12: 500-1000 mcg daily (methylcobalamin or hydroxocobalamin preferred)
  • Folate: 400-800 mcg daily (methylfolate for those with MTHFR mutations)
  • Vitamin B6: 25-50 mg daily (as pyridoxal-5-phosphate)
  • Consider a high-quality B-complex supplement for comprehensive support

For individuals with severe deficiency or malabsorption issues, higher doses or injectable forms may be necessary initially. Always work with a healthcare provider to determine the appropriate dosing for your specific situation.

Dietary Approaches

While supplementation is often necessary to correct deficiencies quickly, optimizing your diet ensures long-term success. Focus on incorporating these B vitamin-rich foods:

  • B12 sources: Fish, meat, poultry, eggs, dairy products, fortified plant milks
  • Folate sources: Dark leafy greens, legumes, citrus fruits, fortified grains
  • B6 sources: Poultry, fish, potatoes, chickpeas, bananas, fortified cereals

Beyond B Vitamins: Other Factors Affecting Homocysteine

While B vitamin deficiency is the most common cause of elevated homocysteine, other factors can contribute to or exacerbate the problem. Understanding these factors helps ensure comprehensive treatment:

  • Kidney disease (reduced clearance of homocysteine)
  • Hypothyroidism (affects B vitamin metabolism)
  • Certain medications (methotrexate, phenytoin, theophylline)
  • Smoking and excessive alcohol consumption
  • High coffee consumption (may interfere with B vitamin absorption)
  • Genetic factors (MTHFR, CBS, and other mutations)
  • Chronic inflammation

Addressing these contributing factors alongside B vitamin supplementation often yields the best results in normalizing homocysteine levels and reducing associated health risks.

Taking Action: Your Path to Optimal Homocysteine Levels

Managing homocysteine levels through B vitamin optimization is one of the most impactful steps you can take for your long-term health. The connection between B vitamins and homocysteine is well-established, and addressing deficiencies can significantly reduce your risk of cardiovascular disease, cognitive decline, and other serious health conditions.

Start by getting your homocysteine and B vitamin levels tested to establish your baseline. If deficiencies are identified, work with your healthcare provider to develop a personalized supplementation and dietary plan. Regular monitoring ensures your interventions are working and allows for adjustments as needed.

Remember that optimal health is not just about avoiding disease—it's about thriving at every stage of life. By maintaining healthy homocysteine levels through adequate B vitamin intake, you're investing in your cardiovascular health, cognitive function, and overall vitality for years to come.

References

  1. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270(22):2693-2698.[PubMed][DOI]
  2. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37,485 individuals. Arch Intern Med. 2010;170(18):1622-1631.[PubMed][DOI]
  3. Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5(9):e12244.[PubMed][DOI]
  4. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.[PubMed][DOI]
  5. Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.[PubMed][DOI]
  6. Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16(8):559-565.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my homocysteine at home?

You can test your homocysteine at home with SiPhox Health's Heart & Metabolic Program, which includes homocysteine testing along with other cardiovascular and metabolic biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the normal range for homocysteine?

Normal homocysteine levels are typically considered to be below 15 μmol/L, but optimal levels are below 10 μmol/L. Levels between 15-30 μmol/L are considered moderately elevated, while levels above 30 μmol/L are severely elevated and require immediate medical attention.

How long does it take to lower homocysteine with B vitamins?

Most people see significant improvements in their homocysteine levels within 4-8 weeks of starting appropriate B vitamin supplementation. However, the exact timeline depends on the severity of the deficiency, the doses used, and individual factors affecting absorption and metabolism.

Can you have high homocysteine without B vitamin deficiency?

Yes, while B vitamin deficiency is the most common cause, other factors can elevate homocysteine including kidney disease, hypothyroidism, certain medications, genetic mutations (like MTHFR), and lifestyle factors such as smoking and excessive alcohol consumption.

Should I take B vitamins if my homocysteine is normal?

If your homocysteine levels are optimal (below 10 μmol/L) and you have no signs of B vitamin deficiency, you may not need supplementation beyond a healthy diet. However, certain groups like vegetarians, older adults, and pregnant women may benefit from B vitamin supplementation regardless of homocysteine levels.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details